 Home > Biochemistry News > Biotechnology News > Takeda's Innovative Therapy Receives FDA Priority Review Qualification to Treat Common Viral Infections After Transplantation Surgery

Takeda's Innovative Therapy Receives FDA Priority Review Qualification to Treat Common Viral Infections After Transplantation Surgery

 Last Update: 2021-06-10
 Source: Internet
 Author: User

Tags

remeron drug class

hbsag treatment

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On May 21, 2021, Takeda announced that the US FDA has accepted a new drug application (NDA) for the oral protein kinase inhibitor maribavir (TAK-620).

CMV infection is one of the most common viral infections in transplant patients.

Maribavir (TAK-620) is a UL97 protein kinase inhibitor with an innovative mechanism to inhibit CMV virus replication.

"CMV infection is one of the most common viral infections experienced by transplant patients, and current antiviral treatment options are limited.

Reference materials:

[1] US Food & Drug Administration Grants Priority Review of Maribavir for the Treatment of Post-Transplant Recipients With Cytomegalovirus Infection in Those Resistant and/or Refractory to Prior Anti-CMV Treatment.

Note: This article aims to introduce the progress of medical and health research, not to recommend treatment options.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.